HOME >> BIOLOGY >> NEWS
Hebrew University, German and British researchers develop means to help stress sufferers

Try as we may to suppress memories of highly stressful experiences, they nevertheless come back to bother us even causing attacks of intense fear or other undesirable behavioral impairments.

Now, a group of German, Israeli and British scientists and students have found that a gene-based approach offers promise for development of a treatment that can suppress these reactions, while not impairing memory itself.

In an article appearing as the cover story in the current issue of Molecular Psychiatry, a team of researchers from the Silberman Institute of Life Sciences at the Hebrew University of Jerusalem and the Max Planck Institute for Experimental Medicine in Goettingen, Germany, describe their work with mice who were subjected to stressful conditions.

The team discovered that this stress induces a change in the expression of the acetylcholinesterase gene. Under normal circumstances, this gene produces a vital protein that adheres to neuronal synapses (the interaction sites through which nerve cells communicate with each other). Following stress, however, the same gene produces large quantities of a protein with modified properties that results in heightened electrical signals in the nerve cells communicating through these synapses. The effect is to create reactions of extreme fright or immobilizing shock.

Later encounter with a context which arouses those stressful memories which might be an object, a sound, an image or other form of association -- can set off that same neuronal reaction. Often, this reaction can have serious consequences, such as chronic fatigue or personality disorders, including post- traumatic stress disorder (PTSD). In the U.S., it is estimated that more than 15 million people a year are identified with PTSD or other anxiety disorders.

The research team at the Hebrew University and in Germany and Britain has succeeded in developing an "antisense" agent that acts to neutralize the process whereby the modified pro
'"/>

Contact: Jerry Barach
jerryb@savion.huji.ac.il
972-2-588-2904
The Hebrew University of Jerusalem
11-Dec-2003


Page: 1 2

Related biology news :

1. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
2. Defensive action by influenza viruses demonstrated by Hebrew university researcher
3. Earliest evidence of hereditary genetic disorder discovered by Hebrew University researchers
4. Scientists in Germany and Hebrew University illuminate process in control of flowering in plants
5. Hebrew University young researcher award goes to Dr. Nayef Jarrous
6. Hebrew University Ph.D. graduate wins young scientist prize in US
7. Hebrew University researcher studies reorganization of brain in blind people
8. Hebrew University researchers develop method to improve neutraceutical absorption
9. Faster method for growing adult stem cells for bone regeneration developed at Hebrew University
10. Hebrew University researcher wins prize for work leading to new anti-cancer drugs
11. Hebrew University excavations strengthen dating of archaeological findings to David, Solomon

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/31/2020)... ... July 30, 2020 , ... BioFactura, Inc. ... awarded by the Joint Science & Technology Office—Chemical and Biological Defense (JSTO-CBD) of ... optimize, and scale-up a highly efficient mammalian cell culture-based bioprocess suitable to meet ...
(Date:7/18/2020)... ... July 16, 2020 , ... A ... of the Invictus Medical Neoasis™ active noise control device to attenuate typical noises ... the Neoasis™ device attenuated the alarm sounds from patient monitors, ventilators and other ...
(Date:7/10/2020)... ... 2020 , ... Today CJ BIO announced the first in a series of ... taste” phenomenon that is revolutionizing ingredient mixes, nutritional content and flavor profiles across a ... July 13, 2020 at11:00 AM (CDT) during SHIFT20, the virtual edition of the IFT ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... N.J (PRWEB) , ... July 29, 2020 , ... ... company, and Catalent, the leading global provider of advanced delivery technologies, development, and ... today announced that they have entered into a strategic partnership whereby Catalent will ...
(Date:7/22/2020)... (PRWEB) , ... July 22, 2020 , ... Join experts ... John Lorenc, Sr. Manager Regulatory Solutions, in a one hour live webinar ... the regulating body in China for drugs and medical devices. Specifically, for medical devices, ...
(Date:7/18/2020)... ... July 17, 2020 , ... dicentra ... life sciences and food industries, is pleased to announce that Charles Galea has ... Business Development. , Charles is an accomplished and results-driven sales executive with over ...
(Date:7/10/2020)... ... July 09, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage ... Allen R. Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. Dr. Nissenson ... product, SBI-101. Dr. Nissenson serves as an Emeritus Professor of Medicine at ...
Breaking Biology Technology:
Cached News: